Königsbrücker Straße (South) between Albertplatz and Stauffenbergallee; Lot 12 GUW 31, Eschenstraße – Elt. – Equipment GUW
Dresdner Verkehrsbetriebe AG, DresdenTED 734186-2026
value not stated1 lot
Fri 18 Dec10:00 in Berlin
50days
Public tenders in Germany
212 open tenders
CountryTenderValueClosesDays left
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Ranibizumab (WHO ATC Code: S01LA04) as injection solution in a vial.
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 748583-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Ranibizumab (WHO ATC Code: S01LA04) as injection solution in a pre-filled syringe.
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 748999-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Golimumab (WHO ATC code: L04AB06)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 692978-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Tocilizumab (WHO ATC code: L04AC07)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 690691-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive discount agreements under § 130a, paragraph 8 of the German Social Code V (SGB V) via an Open-House (OH) model for Aflibercept (WHO ATC-code: S01LA05; excluding 114, 3 mg/ml) as an injectable solution in a pre-filled syringe
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 749886-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive discount agreements under § 130a, paragraph 8 of the German Social Code V (SGB V) via an Open-House (OH) model for Aflibercept (WHO ATC-code: S01LA05; excluding 114, 3 mg/ml) as an injectable solution in a vial
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 750728-2025
value not stated1 lot
Thu 31 Dec23:58 in Berlin
63days
Conclusion of non-exclusive drug discount agreements under § 130a para. 8 SGB V via an Open-House model for the active ingredient Pazopanib (WHO ATC code: L01EX03)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 739760-2025
value not stated1 lot
Sun 31 Jan23:58 in Berlin
94days
Conclusion not exclusively of a discount agreement for pharmaceuticals pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active substance Dexamethasone (WHO ATC-code: S01BA01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 857590-2025
value not stated1 lot
Sun 28 Feb23:58 in Berlin
122days
Conclusion of non-exclusive discount agreements for Oxycodone/Naloxone (WHO ATC-code: N02AA55) under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 383818-2026
value not stated1 lot
Wed 31 Mar23:58 in Berlin
153days
Conclusion of non-exclusive agreements on medicinal products containing the active substance Ponesimod (ATC Code: L04AE04) via an open-house model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 162615-2026
value not stated1 lot
Fri 30 Apr23:58 in Berlin
183days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Beclometasone/Formoterol (WHO ATC Code: R03AK08)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 176734-2026
value not stated1 lot
Mon 31 May23:58 in Berlin
214days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Tamsulosin/Dutasteride (WHO ATC Code: G04CA52)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 803445-2025
value not stated1 lot
Mon 31 May23:58 in Berlin
214days
Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Apremilast (WHO ATC Code: L04AA32)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 811450-2025
value not stated1 lot
Mon 31 May23:59 in Berlin
214days
Non-exclusive drug rebate agreements concluded under § 130a Abs. 8 SGB V via an open-house model for the active substance Denosumab Prolia (WHO ATC code: M05BX04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 451344-2026
value not stated1 lot
Mon 31 May23:59 in Berlin
214days
Conclusion of non-exclusive medicine discount agreements pursuant to § 130a paragraph 8 SGB V via an Open-House model for the active substance Formoterol/Aclidinium bromide (WHO ATC-code: R03AL05)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 309969-2026
value not stated1 lot
Wed 30 Jun23:58 in Berlin
244days
Conclusion of non-exclusive medicine discount agreements pursuant to § 130a paragraph 8 SGB V via an Open-House model for the active substance Liraglutide (WHO ATC-code: A10BJ02; official ATC: A10BJ02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 309108-2026
value not stated1 lot
Wed 30 Jun23:58 in Berlin
244days
Conclusion of non-exclusive agreements for medicines with the active substance Nintedanib (ATC-code: L01EX09), via an Open-House model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 232797-2026
value not stated1 lot
Wed 30 Jun23:58 in Berlin
244days
Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Nilotinib (WHO ATC code: L01EA03)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 308469-2026
value not stated1 lot
Sat 31 Jul23:58 in Berlin
275days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Denosumab Xgeva (WHO ATC Code: M05BX04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 464454-2026
value not stated1 lot
Sat 31 Jul23:58 in Berlin
275days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.